The U.S. Food and Drug Administration is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for children 12 to 15 years old, a decision that could come by some time early next week. The vaccine is currently authorized only for people age 16 and older. A ruling should come "shortly," Pfizer Chairman and CEO Albert Bourla told investors in a conference call Tuesday morning. The company announced in late March that it would ask the FDA to expand its emergency use authorization to allow younger people to receive the vaccine, citing clinical trials that showed the vaccine elicits "100% efficacy and robust antibody responses" in adolescents from 12 to 15 years old. News of the pending authorization comes as children now represent a rising proportion...
READ MORE >
Pfizer Says FDA Will Soon Authorize COVID-19 Vaccine For 12-15 Age Group